Strattera classification
Pro Research Analysisby 
Searched over 200M research papers for "strattera classification"
Consensus Meter
Strattera Classification: Understanding Its Pharmacological Category
Introduction to Strattera
Strattera, known generically as atomoxetine, is a medication primarily used to treat Attention Deficit Hyperactivity Disorder (ADHD). Unlike many other ADHD medications, Strattera is not a stimulant. This distinction is crucial for understanding its classification and mechanism of action.
Pharmacological Classification of Strattera
Non-Stimulant ADHD Medication
Strattera is classified as a non-stimulant medication for ADHD. This sets it apart from other common ADHD treatments like methylphenidate (Ritalin) and amphetamine salts (Adderall), which are stimulants. Non-stimulant medications are often preferred for patients who may not respond well to stimulants or who have a history of substance abuse.
Selective Norepinephrine Reuptake Inhibitor (NRI)
Strattera functions as a selective norepinephrine reuptake inhibitor (NRI). This means it works by increasing the levels of norepinephrine, a neurotransmitter, in the brain. Norepinephrine plays a key role in attention and behavior regulation, which is why increasing its availability can help manage ADHD symptoms effectively.
Mechanism of Action
Norepinephrine Modulation
The primary action of Strattera is to inhibit the reuptake of norepinephrine at the synaptic cleft. By preventing the reabsorption of this neurotransmitter, Strattera increases its concentration in the brain, thereby enhancing attention and reducing hyperactive and impulsive behaviors associated with ADHD.
Non-Stimulant Benefits
One of the significant benefits of Strattera being a non-stimulant is its lower potential for abuse compared to stimulant medications. This makes it a safer option for individuals with a history of substance abuse or those who are at risk of developing dependency.
Conclusion
Strattera (atomoxetine) is a non-stimulant medication classified as a selective norepinephrine reuptake inhibitor (NRI). It is used to treat ADHD by increasing norepinephrine levels in the brain, which helps improve attention and reduce hyperactivity and impulsivity. Its non-stimulant nature makes it a valuable alternative for patients who may not tolerate stimulant medications well or are at risk of substance abuse.
Sources and full results
Most relevant research papers on this topic